Cytek Biosciences Inc (CTKB) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Cytek Biosciences Inc   (NASDAQ: CTKB)
 

Cytek Biosciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Cytek Biosciences Inc 's inventory turnover ratio sequentially decreased to 1.9 in the second quarter 2026, otherwise the ratio remained above the average, as CTKB's markets remain strong.Cytek Biosciences Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 192 days, from 186 days, in the Mar 31 2026 quarter.

Within Healthcare sector 216 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 920 in the first quarter 2026, to 1587.

CTKB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cytek Biosciences Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTKB Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 5.59 % 9.8 % 10.33 % 10.36 % -1.16 %
Y / Y Cost of Sales Growth -8.9 % 4.76 % 20 % 9.09 % 3.5 %
Inventory Turnover Ratio (TTM) 1.9 1.96 1.99 1.93 1.93
CTKB's Total Ranking # 1587 # 920 # 1117 # 985 #
Average inventory processing period 193 186 184 189 189
Seq. Inventory Growth 4.94 % 2.81 % -6.24 % 4.37 % 9.13 %
Seq. Cost of Sales Growth -10 % -26.67 % 25 % 10.42 % 3.5 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 12
Healthcare Sector # 217
Overall Market # 1587

Inventory Turnover Ratio Statistics
High Average Low
1.99 1.63 1.2
(Dec 31 2025)   (Jun 30 2023)



CTKB Company Profile >> Back to CTKB Efficiency Comparisons >> Compare CTKB Inventory Turnover Ratio to its Competitors

Financial Statements
Cytek Biosciences Inc 's Inventories $ 52 Millions Visit CTKB's Balance sheet
Cytek Biosciences Inc 's Cost of Revenues TTM $ 96 Millions Visit CTKB's Income Statement
What are CTKB's Sales? Visit CTKB's Sales by Segment

Other Inventory Turnover Ratios
Cytek Biosciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CTKB's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CTKB's Competitors
Inventory Turnover Ratio for CTKB's Suppliers
Inventory Turnover Ratio for CTKB's Customers

You may also want to know
CTKB's Sales Growth Rates CTKB's Pe Price to earnings ratio CTKB's Receivables Turnover Ratio CTKB's Stock Quote
CTKB's Net Income Growth Rates CTKB's Ps Price to Sales ratio CTKB's Sales per Employee CTKB's Asset Turnover Ratio
CTKB's Net Margin CTKB's Pb Price to Book ratio CTKB's Financial Strength Ratios CTKB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Escalon Medical Corp   3.94 $ 7.167  Millions$ 2  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.